Clinical Features of β-Thalassemia and Sickle Cell Disease.

about

Clinical Features of β-Thalassemia and Sickle Cell Disease.

Item

http://www.wikidata.org/entity/Q50061141

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@en

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@nl

type

Item

label

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@en

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@nl

prefLabel

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@en

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@nl

P1476

Clinical Features of β-Thalassemia and Sickle Cell Disease.

@en

P2093

Alecia C Nero

http://www.w3.org/2001/XMLSchema#string

Patrick T McGann

http://www.w3.org/2001/XMLSchema#string

Russell E Ware

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment for avascular necrosis of bone in people with sickle cell disease

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases

Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis

Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia

Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results

Silent cerebral infarcts: a review on a prevalent and progressive cause of neurologic injury in sickle cell anemia

The inherited diseases of hemoglobin are an emerging global health burden.

Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.

Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura.

P304

1-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-7299-9_1

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1013

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29127675

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease